Marathon Trading Investment Management »

Neuropace shares owned by Marathon Trading Investment Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Marathon Trading Investment Management from 13F filings

Historical chart of Marathon Trading Investment Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Marathon Trading Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Marathon Trading Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $370k 28k 13.20

More positions owned by Marathon Trading Investment Management

Spdr S&p 500 Etf Tr Option Put Option
United States Stl Corp Option Put Option
Chevron Corp Option Put Option
Ishares Tr Option Call Option
Bank America Corp Option Put Option
United States Stl Corp Option Call Option
Citigroup Common Stock (C)
Citigroup Option Put Option
Bank America Corp Common Stock (BAC)
Capri Holdings Option Put Option
Spdr S&p 500 Etf Tr Option Call Option
Invesco Qqq Tr Common Stock (QQQ)
Hess Corp Option Call Option
Wells Fargo Option Put Option
Bank America Corp Option Call Option

View all positions for Marathon Trading Investment Management

Top funds holding Neuropace

OrbiMed Advisors
Morgan Stanley
Soleus Capital Management
Nantahala Capital Management
Kent Lake Capital
Millennium Management
Vanguard Group
FMR
Susquehanna International
Goldman Sachs Group
Geode Capital Management
Citigroup
Eudaimonia Asset Management
BlackRock
Jane Street

View all funds holding Neuropace